ZHANG Fuyuan,JIANG Quan,LI Da,et al.Research Thinking on Remodeling Bone Immune Microenvironment of Rheumatoid Arthritis with Qingre Huoxue Formulaand Medicinals (清热活血方药)[J].Journal of Traditional Chinese Medicine,2023,64(10):999-1003.
ZHANG Fuyuan,JIANG Quan,LI Da,et al.Research Thinking on Remodeling Bone Immune Microenvironment of Rheumatoid Arthritis with Qingre Huoxue Formulaand Medicinals (清热活血方药)[J].Journal of Traditional Chinese Medicine,2023,64(10):999-1003.DOI: 10.13288/j.11-2166/r.2023.10.006.
Research Thinking on Remodeling Bone Immune Microenvironment of Rheumatoid Arthritis with Qingre Huoxue Formulaand Medicinals (清热活血方药)
Osteoclasts play a major role in the bone destruction of rheumatoid arthritis (RA). In the bone immune microenvironment, immune cells can secrete cytokines, chemokines, growth factors and extracellular matrix proteins through complex communication networks. Proteins regulate osteoclasts, and osteoclasts can react on immune cells to achieve two-way regulation and spatial interaction. It is believed that “damp, heat and stasis” are the core pathogenesis of RA, and damp-heat obstruction is the main syndrome of bone destruction. Therefore,
Qingre Huoxue Formula
and Medicinals
(清热活血方药) is proposed to regulate the inflammatory response of RA through multiple channels and multiple targets, thereby remodeling the bone immune microenvironment and delaying bone destruction.
TATEIWA D , YOSHIKAWA H , KAITO T . Cartilage and bone destruction in arthritis: pathogenesis and treatment strategy: a literature review [J]. Cells , 2019 , 8 ( 8 ): 818 .
LIN Y J , ANZAGHE M , SCHULKE S . Update on the path mechanism, diagnosis, and treatment options for rheumatoid arthritis [J]. Cells , 2020 , 9 ( 4 ): 880 .
FRAENKEL L , BATHON JM , ENGLAND BR , et al . 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis [J]. Arthritis Care Res (Hoboken) , 2021 , 73 ( 7 ): 924 - 939 .
GUO Q , WANG Y , XU D , et al . Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies [J]. Bone Res , 2018 , 6 ( 7 ): 15 .
MCINNES IB , SCHETT G . Pathogenetic insights from the treatment of rheumatoid arthritis [J]. Lancet , 2017 , 389 ( 10086 ): 2328 - 2337 .
REDLICH K , HAYER S , RICCI R , et al . Osteoclasts are essential for TNF-alpha-mediated joint destruction [J]. J Clin Invest , 2002 , 110 ( 10 ): 1419 - 1427 .
BAUM R , GRAVALLESE EM . Impact of inflammation on the osteoblast in rheumatic diseases [J]. Curr Osteoporos Rep , 2014 , 12 ( 1 ): 9 - 16 .
BOYCE BF . Advances in the regulation of osteoclasts and osteoclast functions [J]. J Dent Res , 2013 , 92 ( 10 ): 860 - 867 .
ONO T , HAYASHI M , SASAKI F , et al . RANKL biology: bone metabolism, the immune system, and beyond [J]. Inflamm Regen , 2020 , 40 : 2 . doi: 10.1186/s41232-019-0111-3 http://dx.doi.org/10.1186/s41232-019-0111-3 .
TAKAYANAGI H . Osteoimmunology and the effects of the immune system on bone [J]. Nat Rev Rheumatol , 2009 , 5 ( 12 ): 667 - 676 .
OKAMOTO K , TAKAYANAGI H . Regulation of bone by the adaptive immune system in arthritis [J]. Arthritis Res Ther , 2011 , 13 ( 3 ): 219 .
LI Y , TORALDO G , LI A , et al . B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo [J]. Blood , 2007 , 109 ( 9 ): 3839 - 3848 .
SAIDENBERG KN , BESSIS N , COHEN-SOLAL M , et al . Osteoprotegerin and inflammation [J]. Eur Cytokine Netw , 2002 , 13 ( 2 ): 144 - 153 .
ASAGIRI M , TAKAYANAGI H . The molecular understanding of osteoclast differentiation [J]. Bone , 2007 , 40 ( 2 ): 251 - 264 .
SHIM JH , STAVRE Z , GRAVALLESE EM . Bone loss in rheumatoid arthritis: basic mechanisms and clinical implications [J]. Calcif Tissue Int , 2018 , 102 ( 5 ): 533 - 546 .
TSUKASAKI M , TAKAYANAGI H . Osteoimmunology: evolving concepts in bone-immune interactions in health and disease [J]. Nat Rev Immunol , 2019 , 19 ( 10 ): 626 - 642 .
SCHLUNDT C , SCHELL H , GOODMAN SB , et al . Immune modulation as a therapeutic strategy in bone rege-neration [J]. J Exp Orthop , 2015 , 2 ( 1 ): 1 .
SCHMIDT-BLEEK K , SCHELL H , LIENAU J , et al . Initial immune reaction and angiogenesis in bone healing [J]. J Tissue Eng Regen Med , 2014 , 8 ( 2 ): 120 - 130 .
TANG M , TIAN L , LUO G , et al . Interferon-gamma-mediated osteoimmunology [J]. Front Immunol , 2018 , 9 : 1508 . doi: org/10.3389/fimmu.2018.01508 http://dx.doi.org/org/10.3389/fimmu.2018.01508 .
WEYAND CM , GORONZY JJ . The immunology of rheumatoid arthritis [J]. Nat Immunol , 2021 , 22 ( 1 ): 10 - 18 .
LEE D , ROJAS OL , GOMMERMAN JL . B cell depletion therapies in autoimmune disease: advances and mechanistic insights [J]. Nat Rev Drug Discov , 2021 , 20 ( 3 ): 179 - 199 .
MEEDNU N , ZHANG H , OWEN T , et al . Production of RANKL by memory B cells: a link between B cells and bone erosion in rheumatoid arthritis [J]. Arthritis Rheumatol , 2016 , 68 ( 4 ): 805 - 816 .
FREYTES DO , KANG JW , MARCOS-CAMPOS I , et al . Macrophages modulate the viability and growth of human mesenchymal stem cells [J]. J Cell Biochem , 2013 , 114 ( 1 ): 220 - 229 .
TAKAYANAGI H . RANKL as the master regulator of osteoclast differentiation [J]. J Bone Miner Metab , 2021 , 39 ( 1 ): 13 - 18 .
LI H , HONG S , QIAN J , et al . Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4 + and CD8 + T cells [J]. Blood , 2010 , 116 ( 2 ): 210 - 217 .
IBANEZ L , ABOU-EZZI G , CIUCCI T , et al . Inflammatory osteoclasts prime TNF alpha-producing CD4 + T cells and express CX3 CR1 [J]. J Bone Miner Res , 2016 , 31 ( 10 ): 1899 - 1908 .
MCDONALD MM , KHOO WH , NG PY , et al . Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption [J]. Cell , 2021 , 184 ( 5 ): 1330 - 1347 .
JIANG Q , ZHOU X , WANG L , et al . A one-year evaluation of radiographic progression in patients with rheumatoid arthritis treated by Qingre Huoxue Decoction .[J]. Chin J Integr Med , 2012 , 18 ( 4 ): 256 - 261 .
Exploring the Correlation between Pyroptosis and Immune Microenvironment Dysregulation in Rheumatoid Arthritis from the Perspective of "Ying Decline and Wei Attack"
Mechanism of Bone Destruction in Rheumatoid Arthritis Based on the Theory of Kidney Deficiency and Essence Deficiency
Discussion on the Targeting Mechanism of Qingre Huoxue Formula (清热活血方) for Treatment of Rheumatoid Arthritis by Regulating “Inflammation-Bone Destruction”:Based on LRG1/TGF- β Signalling Axis
Medication Principles of Chinese Medicine Treating Rheumatoid Arthritis Bone Destruction: Based on Text Mining
Correlation Between Traditional Chinese Medicine Syndromes and Rheumatoid Arthritis with Atherosclerosis:A Multicenter Cross-Sectional Study
Related Author
LI Yancun
ZHU Shu
WANG Yuhan
QU Yuan
LIU Yuan
JIANG Ping
ZHU Wenju
SU Xiaojun
Related Institution
Shandong University of Traditional Chinese Medicine
Gansu University of Chinese Medicine
Gansu Provincial Hospital of Traditional Chinese Medicine
Lanzhou University No.2 Hospital
Chaoyang Tenth Retired Cadre Rehabilitation Center of the Beijing Garrison of the People's Liberation Army of China